NEW YORK, NY, ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series C financing.
ProofPilot has announced the closing of its Series C financing, led by Sopris Capital with Mitsui & Co. (U.S.A.), Inc. participating.
ProofPilot enhances clinical trials with its Clinical Experience Platform (CXP). The StudyCoPilot platform centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
